Zepbound Heartburn: How Common, How Long It Lasts
Yes. In the Zepbound trials, 10% of people on 15 mg had heartburn and indigestion, against 4% on placebo: about 2 times the placebo rate. It is the fifth most common side effect in that table. Smaller, slower meals help most.
- In the Zepbound label
- Yes, with a rate
- On Zepbound 15 mg
- 10%
- On placebo
- 4%
- Rank in the label table
- 5 of 16
Zepbound: key facts
The drug has a half-life of 5 to 6 days. At 5.5 d, half is gone. After five half-lives (27.5 d), about 3% remains.
At 72 weeks in SURMOUNT-1, the figure was 20.9% of body weight, versus 3.1% with placebo.
For US dollars, the monthly figures show the list price and self-pay offers. Each amount comes from the maker's price page.
Sources: FDA label (DailyMed), Eli Lilly 1 2, cnbc.com.
How often it appears with Zepbound compared with placebo
The Zepbound label trials group Zepbound heartburn results by dose. Placebo was the comparison group in that same trial.
| Medicine and dose | Heartburn and indigestion | Placebo | More than placebo | People in the trials |
|---|---|---|---|---|
| Zepbound 5 mg | 9% | 4% | +5 points | Adults with obesity or excess weight (weight management) (label term: dyspepsia) |
| Zepbound 10 mg | 9% | 4% | +5 points | Adults with obesity or excess weight (weight management) (label term: dyspepsia) |
| Zepbound 15 mg | 10% | 4% | +6 points | Adults with obesity or excess weight (weight management) (label term: dyspepsia) |
| Zepbound 5 mg | 4% | 2% | +2 points | For weight management, adults with obesity or overweight (label term: gastroesophageal reflux disease) |
| Zepbound 10 mg | 4% | 2% | +2 points | For weight management, adults with obesity or overweight (label term: gastroesophageal reflux disease) |
| Zepbound 15 mg | 5% | 2% | +3 points | For weight management, adults with obesity or overweight (label term: gastroesophageal reflux disease) |
Source: Zepbound label (DailyMed).
Comparing Heartburn with Zepbound and other GLP-1s
Each label covers its own trials, and the groups of people differ. Treat it as a rough guide.
Foundayo pill forms are also included in the table.
| Medicine | Highest rate in the label | Dose group | Placebo | People in the trials |
|---|---|---|---|---|
 Foundayo | 16% | 9 mg | 4% | Adults with obesity or overweight (weight management) |
| Zepbound | 10% | 15 mg | 4% | Adults with obesity or overweight (weight management) |
 Saxenda | 9.6% | all doses | 2.7% | Adults with obesity or overweight (weight management) |
 Wegovy | 9% | 2.4 mg | 3% | Adults with obesity or overweight (weight management) |
 Mounjaro | 8% | 5 mg | 3% | Adults with type 2 diabetes |
 Victoza | 7% | 1.8 mg | 1% | Adults with type 2 diabetes |
| Byetta | 6% | all doses | 3% | Adults with type 2 diabetes |
 Trulicity | 5.8% | 1.5 mg | 2.3% | Adults with type 2 diabetes |
 Ozempic | Listed, no rate given | – | – | – |
 Rybelsus | Listed, no rate given | – | – | – |
Sources: Wegovy label (DailyMed), Mounjaro label (DailyMed), Zepbound label (DailyMed), Foundayo label (DailyMed), Trulicity label (DailyMed), Saxenda label (DailyMed), Victoza label (DailyMed), Byetta label (DailyMed).
Source: DailyMed FDA label.
The reasons it happens with Zepbound
The stomach empties more slowly because of these medicines. Food remains in your stomach longer, so heartburn and indigestion may follow, especially after a large or fatty meal.
Source: health.clevelandclinic.org.
What helps, step by step
- For now, avoid foods that are spicy or fatty.
- Stay upright after eating instead of lying down.
- Eat smaller meals and stop when you feel full. These medicines make the stomach empty more slowly.
- Eat slowly. It takes time for your brain to sense that you are full.
- Foods high in fat, grease, or sugar often cause symptoms, so have less of them.
- If it does not ease, tell your prescriber. Your prescriber may slow the dose increases, or may suggest another GLP-1.
Before taking anything from the drugstore, check it with the GLP-1 interactions tool.
Source: health.clevelandclinic.org.